Literature DB >> 21969033

NF-κB and cancer: a paradigm of Yin-Yang.

Gutian Xiao1, Jing Fu.   

Abstract

Recent studies have clearly linked nuclear factor-kappaB (NF-κB), a transcription factor that plays a central role in regulating immune and inflammatory responses, to tumor development, progression, and metastasis as well as tumor therapy resistance. However, it still remains largely unknown on how the tightly regulated NF-κB becomes constitutively activated in tumorigenesis and how the original cancer immunosurveillance function of NF-κB is transformed to be tumorigenic. To address these important issues for cancer prevention and treatment, we discuss current understanding of the molecular mechanisms and molecules involved in the oncogenic activation of NF-κB. We also discuss current understanding of how NF-κB coordinates the inflammatory and malignant cells in tumorigenesis.

Entities:  

Year:  2010        PMID: 21969033      PMCID: PMC3180046     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  310 in total

1.  Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.

Authors:  S Descamps; R A Toillon; E Adriaenssens; V Pawlowski; S M Cool; V Nurcombe; X Le Bourhis; B Boilly; J P Peyrat; H Hondermarck
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

2.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.

Authors:  Fengjun Wang; Zhiguo Zheng; Jiangfeng Guo; Xianfeng Ding
Journal:  Gynecol Oncol       Date:  2010-12       Impact factor: 5.482

4.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

5.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

6.  The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.

Authors:  Qinmiao Sun; Sunny Zachariah; Preet M Chaudhary
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

Review 7.  Autophagy and NF-kappaB: fight for fate.

Authors:  Gutian Xiao
Journal:  Cytokine Growth Factor Rev       Date:  2007-05-07       Impact factor: 7.638

8.  Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.

Authors:  Guoliang Qing; Pengrong Yan; Zhaoxia Qu; Hudan Liu; Gutian Xiao
Journal:  Cell Res       Date:  2007-06       Impact factor: 25.617

Review 9.  Modelling oncogenic Ras/Raf signalling in the mouse.

Authors:  Florian A Karreth; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2009-02-07       Impact factor: 5.578

10.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

View more
  40 in total

Review 1.  Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.

Authors:  Spiros A Vlahopoulos; Osman Cen; Nina Hengen; James Agan; Maria Moschovi; Elena Critselis; Maria Adamaki; Flora Bacopoulou; John A Copland; Istvan Boldogh; Michael Karin; George P Chrousos
Journal:  Cytokine Growth Factor Rev       Date:  2015-06-20       Impact factor: 7.638

2.  Targeting NF-κB p65 with a Helenalin Inspired Bis-electrophile.

Authors:  John C Widen; Aaron M Kempema; Peter W Villalta; Daniel A Harki
Journal:  ACS Chem Biol       Date:  2016-11-28       Impact factor: 5.100

3.  Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns.

Authors:  Soo Jeong Park; Jeong Mi Kim; Jihyo Kim; Jaehark Hur; Sun Park; Kyongmin Kim; Ho-Joon Shin; Yong-Joon Chwae
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

4.  Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.

Authors:  Fan Sun; Yadong Xiao; Zhaoxia Qu
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

5.  NF-κB RelA renders tumor-associated macrophages resistant to and capable of directly suppressing CD8+ T cells for tumor promotion.

Authors:  Liwen Li; Lei Han; Fan Sun; Jingjiao Zhou; Kim C Ohaegbulam; Xudong Tang; Xingxing Zang; Kris A Steinbrecher; Zhaoxia Qu; Gutian Xiao
Journal:  Oncoimmunology       Date:  2018-02-27       Impact factor: 8.110

6.  Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells.

Authors:  Hye-Sook Seo; Han-Seok Choi; Soon-Re Kim; Youn Kyung Choi; Sang-Mi Woo; Incheol Shin; Jong-Kyu Woo; Sang-Yoon Park; Yong Cheol Shin; Seong-Gyu Ko; Seong-Kyu Ko
Journal:  Mol Cell Biochem       Date:  2012-04-20       Impact factor: 3.396

7.  Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Authors:  Christine L Kragh; Amanda M Gysbers; Edward Rockenstein; Karen Murphy; Glenda M Halliday; Eliezer Masliah; Poul Henning Jensen
Journal:  Neurobiol Dis       Date:  2013-12-17       Impact factor: 5.996

8.  Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Authors:  Z Sheng Guo; Zuqiang Liu; David L Bartlett; Daolin Tang; Michael T Lotze
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

9.  PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage.

Authors:  J Barroso-González; S Auclair; S Luan; L Thomas; K M Atkins; J E Aslan; L L Thomas; J Zhao; Y Zhao; G Thomas
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

Review 10.  NF-κB in colorectal cancer.

Authors:  Aristeidis G Vaiopoulos; Kalliopi Ch Athanasoula; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.